Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy-Reference-Cited by-同舟云学术

Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy

Published:2023-12 Issue:12 Volume:4 Page:100590
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Tanizaki Junko^ORCID,Kuroda Hiroaki,Yokoyama Toshihide,Takahama Makoto,Shoda Hiroyasu,Nakamura Atsushi,Kitamura Yoshitaka,Mamesaya Nobuaki,Kadota Yoshihisa,Sawa Kenji,Okishio Kyoichi,Okada Morihito,Suminaka Chihiro,Noda Kenta,Sakai Kazuko,Chiba Yasutaka,Nishio Kazuto,Chamoto Kenji,Honjo Tasuku,Yamamoto Nobuyuki,Nakagawa Kazuhiko,Hayashi Hidetoshi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial;Felip;Lancet,2021

2. Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial;O’Brien;Lancet Oncol,2022

3. Soluble CD86 is a costimulatory molecule for human T lymphocytes;Jeannin;Immunity,2000

4. Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis;Greisen;Scand J Rheumatol,2014

5. Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study;Jovanovic;J Thorac Dis,2018